Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma

Bone Marrow Transplantation

Volumn 34, Issue 1, 2004, Pages 43-49

  Kim, H ^a   Sohn, H J ^a   Kim, S E ^a   Kang, H J ^a   Park, S ^a   Kim, S ^a   Kim, W K ^a   Lee, J S ^a   Suh, C ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b NONE   (South Korea)

Author keywords

Autologous peripheral blood stem cell transplantation; Lymphocyte; Survival; T cell non Hodgkin's lymphoma

Indexed keywords

BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; MESNA; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGE DISTRIBUTION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CELLULAR IMMUNITY; CHEMOSENSITIVITY; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; LYMPHOCYTE COUNT; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; IMMUNE SYSTEM; LEUKOPOIESIS; LYMPHOCYTE COUNT; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGENERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SURVIVORS;

EID: 3543072230     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704530     Document Type: Article

References (27)

1. Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91-97.
2. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540-1545.
3. Antman KH, Heitjan DF, Hortobagyi GN. High-dose chemotherapy for breast cancer. JAMA 1999; 282: 1701-1703.
4. Berry DA, Broadwater G, Klein JP et al. High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 2002; 20: 743-750.
5. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
6. Porrata LF, Litzow MR, Tefferi A et al. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 2002; 16: 1311-1318.
7. Porrata LF, Gertz MA, Inwards DJ et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 2001; 98: 579-585.
8. Porrata LF, Ingle JN, Litzow MR et al. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Bone Marrow Transplant 2001; 28: 865-871.
9. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
10. Gordan LN, Sugrue MW, Lynch JW et al. Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma. Bone Marrow Transplant 2003; 31: 1009-1013.
11. Heitger A, Neu N, Kern H et al. Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood 1997; 90: 850-857.
12. Schlenke P, Sheikhzadeh S, Weber K et al. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 28: 251-257.
13. Reimer P, Kunzmann V, Wilhelm M et al. Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT). Ann Hematol 2003; 82: 263-270.
14. Fagnoni FF, Lozza L, Zibera C et al. T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8+ subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence. Immunoloyy 2002; 106: 27-37.
15. Douek DC, Vescio RA, Betts MR et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000; 355: 1875-1881.
16. Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471-1490.
17. Damiani D, Stocchi R, Masolini P et al. Dendritic cell recovery after autologous stem cell transplantation. Bone Marrow Transplant 2002; 30: 261-266.
18. Akpek G, Lenz G, Lee SM et al. Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloiclosis. Bone Marrow Transplant 2001; 28: 1105-1109.
19. Nagatoshi Y, Kawano Y, Watanabe T et al. Hematopoietic and immune recovery after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation in a pediatric population. Pediatr Transplant 2002; 6: 319-326.
20. Steingrimsdottir H, Gruber A, Bjorkholm M et al. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Haematologica 2000; 85: 832-838.
21. Tayebi H, Lapierre V, Saas P et al. Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft. Br J Haematol 2001; 114: 698-700.
22. Ottinger HD, Beelen DW, Scheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775-2779.
23. Pierelli L, Perillo A, Ferrandina G et al. The role of growth factor administration and T-cell recovery aftor peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSF. Transfusion 2001; 41: 1577-1585.
24. Baris D, Zahm SH. Epidemiology of lymphomas. Curr Opin Oncol 2000; 12: 383-394.
25. Ministry of Health and Welfare. Annual Report of the Korea Central Cancer Registry 2001 (Published in 2003).
26. Ko YH, Kim CW, Park CS et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998; 83: 806-812.
27. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909-3918.